HomeBLSIF • OTCMKTS
add
Britannia Life Sciences Inc
Market cap
10.55M CAD
P/E ratio
-
Dividend yield
-
Primary exchange
CNSX
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 1.74M | -4.02% |
Operating expense | 1.18M | 0.83% |
Net income | -136.85K | -125.56% |
Net profit margin | -7.87 | -126.62% |
Earnings per share | — | — |
EBITDA | 47.02K | -31.63% |
Effective tax rate | -181.06% | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 990.37K | -42.29% |
Total assets | 22.17M | -3.47% |
Total liabilities | 16.33M | 47.61% |
Total equity | 5.84M | — |
Shares outstanding | 162.25M | — |
Price to book | — | — |
Return on assets | -1.90% | — |
Return on capital | -3.22% | — |
Cash Flow
Net change in cash
| (CAD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -136.85K | -125.56% |
Cash from operations | 692.42K | 20.21% |
Cash from investing | -103.13K | 89.17% |
Cash from financing | -574.51K | -19.32% |
Net change in cash | 13.19K | 101.64% |
Free cash flow | 379.92K | -54.57% |
About
Founded
2000
Headquarters
Website
Employees
28
